Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 467Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Dexilant

PharmaCompass

01

Brand Name : Dexilant

Dexlansoprazole

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Dexilant

arrow
2024 ACI Convention
Not Confirmed

Dexlansoprazole

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2019 Revenue in Millions : 579

2018 Revenue in Millions : 638

Growth (%) : -9

blank

02

Brand Name : Dexilant

Dexlansoprazole

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Dexilant

arrow
2024 ACI Convention
Not Confirmed

Dexlansoprazole

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2020 Revenue in Millions : 553

2019 Revenue in Millions : 591

Growth (%) : -6

blank

03

Brand Name : Dexilant

Dexlansoprazole

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Dexilant

arrow
2024 ACI Convention
Not Confirmed

Dexlansoprazole

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2021 Revenue in Millions : 441

2020 Revenue in Millions : 531

Growth (%) : -10

blank

04

Brand Name : Dexilant

Dexlansoprazole

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Dexilant

arrow
2024 ACI Convention
Not Confirmed

Dexlansoprazole

Main Therapeutic Indication : Gastrointestinal Diseases

Currency : USD

2022 Revenue in Millions : 507

2021 Revenue in Millions : 441

Growth (%) : 15

blank

05

Brand Name : Dexilant

Dexlansoprazole

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Dexilant

arrow
2024 ACI Convention
Not Confirmed

Dexlansoprazole

Main Therapeutic Indication : Gastrointestinal Diseases

Currency : USD

2023 Revenue in Millions : 344

2022 Revenue in Millions : 507

Growth (%) : -23

blank

06

Brand Name : Dexilant

Dexlansoprazole

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Dexilant

arrow
2024 ACI Convention
Not Confirmed

Dexlansoprazole

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2016 Revenue in Millions : 590

2015 Revenue in Millions : 663

Growth (%) : -11

blank

07

Brand Name : Dexilant

Dexlansoprazole

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Dexilant

arrow
2024 ACI Convention
Not Confirmed

Dexlansoprazole

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2017 Revenue in Millions : 650

2016 Revenue in Millions : 629

Growth (%) : 3

blank

08

Brand Name : Dexilant

Dexlansoprazole

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Dexilant

arrow
2024 ACI Convention
Not Confirmed

Dexlansoprazole

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2018 Revenue in Millions : 617

2017 Revenue in Millions : 609

Growth (%) : 1%

blank